Mr Glyn Edwards, MBE
Glyn Edwards has held the position of CEO of Summit plc since April 2012 where he has restructured the business, taken the company through a NASDAQ listing and focused on its infectious and rare disease clinical development programs. Prior to joining Summit, he served as interim CEO of the BioIndustry Association (BIA), a UK trade organisation, from November 2011 to June 2012, and as CEO at Antisoma plc, a biotechnology company specialising in the development of novel drugs for the treatment of cancer, from 1998 to 2011. He received a BSc in Biochemistry from Bristol University and a MSc in Economics from the London Business School. Mr Edwards was awarded an MBE for his services to the biotechnology industry in 2006. In October 2017 he joined the board of OxSonics as a Non-Executive Director and as a member of the company’s Remuneration Committee.